AveGene AG
Health Tech / Digital Health · Appenzell, Appenzell Innerrhoden
AveGene AG is a Swiss health tech / digital health company based in Appenzell, Canton of Appenzell Innerrhoden (UID CHE-175.016.824).
Board members & signatories
- Andreas Scherrer — Präsident des Verwaltungsrates
- Michal Horácek — Mitglied des Verwaltungsrates
Registered purpose
Die Unternehmung bezweckt die Erbringung von Dienstleistungen im Bereich Genetik, einschliesslich Diagnose, Beratung und Datenverarbeitung, sowie in der Forschung und Entwicklung von biologischen, pharmazeutischen und medizinischen Produkten. Die Unternehmung bietet Projektleitung, Beratung, Handel und Vertrieb von pharmazeutischen, diagnostischen und biotechnischen Produkten, medizinischen Geräte…
Source: Swiss commercial register (Zefix / SOGC) and Alpintel analysis · Data as of March 2026
What AveGene does
OFFERING
AveGene AG offers advanced genetic screening tests for cancer detection, including a micro panel for colorectal and lung cancers that identifies 18 oncogenes. Their services also include HPV screening for both males and females, and a complex genetic cancer screening test that evaluates over 126 oncogenic parameters from blood samples.
Unlock the full analysis →Similar companies
- Novigenix SA — Medical Devices & Equipment · Epalinges
- Anaveon AG — Pharmaceuticals · Basel
- Genevant Sciences GmbH — Biotechnology · Basel
- Aurealis Therapeutics AG — Biotechnology · Zug
- Navignostics AG — Health Tech / Digital Health · Horgen
- CORETAG Diagnostics AG — Biotechnology · Basel
Find every health tech / digital health company in Switzerland
Alpintel searches all 710,000 Swiss companies with AI — filter by industry, size, revenue, region and ownership in seconds.
family-owned health tech / digital health companies with 50+ employees…Search →Full profiles from CHF 49/month · Cancel anytime